1-13 of 13
Mei Sheng Duh, MPH
Close
Sort by
Journal Articles

Cost Offsets in the Treatment Journeys of Patients with Relapsed/Refractory Multiple Myeloma (RRMM)

Sikander Ailawadhi, Maral DerSarkissian, PhD, Mei Sheng Duh, MPH, ScD, Marie-Hélène Lafeuille, MA, George Posner, BA, Stephen Ralston, PhD, Erin Zagadailov, PharmD, MS, Abbie Ba-Mancini, MSc, MBA, Robert M Rifkin, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5599.
https://doi.org/10.1182/blood.V130.Suppl_1.5599.5599
Published: 2017
Journal Articles

A Retrospective Chart Review to Assess Burden of Illness Among Patients with Severe Aplastic Anemia with Insufficient Response to Immunosuppressive Therapy

Regis Peffault De Latour, MD PhD, Lynn Huynh, Jasmina I. Ivanova, Todor Totev, BSc, Mehmet Bilginsoy, BA, Joseph H. Antin, MD, Anuja Roy, PhD, Mei Sheng Duh, MPH, ScD
Journal: Blood
Blood (2017) 130 (Supplement 1): 678.
https://doi.org/10.1182/blood.V130.Suppl_1.678.678
Published: 2017
Journal Articles

Treatment Characteristics and Deep Molecular Response in Chronic Phase - Chronic Myeloid Leukemia Patients Treated with Second-Line Nilotinib or Dasatinib: A Multi-Country Retrospective Chart Review Study

Jorge E. Cortes, MD, Lynn Huynh, Estella Mendelson, PhD, Patricia Brandt, PhD, Darshan Dalal, MPH, MD PhD, Maral Dersarkissian, PhD, Diego Cortina, MD MSc, Sahil Narkhede, BA, Mei Sheng Duh, MPH, ScD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2897.
https://doi.org/10.1182/blood.V130.Suppl_1.2897.2897
Published: 2017
Journal Articles

Epidemiologic and Clinical Characteristics of Thalassemia (Thal) Intermedia (TI) in the United States

Elliott P. Vichinsky, MD, Janet Kwiatkowski, MD, Patricia J. Giardina, MD, Carole Paley, MD, Francis Vekeman, MA, Wendy Y. Cheng, MPH, MPhil, Joseph Damron, BA, Nora McCormick, MSc, Medha Sasane, PhDBPharm,MS, Ying Qiu, PhD, Mei Sheng Duh, MPH, ScD, Alexis A. Thompson, MD
Journal: Blood
Blood (2015) 126 (23): 3279.
https://doi.org/10.1182/blood.V126.23.3279.3279
Published: 2015
Journal Articles

Subcutaneous (SQ) Bortezomib (BTZ) in Patients (Pts) with Relapsed Mantle Cell Lymphoma (MCL): Retrospective, Observational Study of Treatment Patterns and Outcomes in US Community Oncology Practices

Alan P Skarbnik, MD, Esprit Ma, MPH, Marie-Hélène Lafeuille, MA, Jonathan Fortier, MA, Tatyana Feldman, MD, Mei Sheng Duh, MPH, ScD, Yvette Ng, MS, MBA, Helgi van de Velde, MD PhD, Edward Dow, MD, Liviu Niculescu, MD, Vijayveer Bonthapally, PhD, Andre Goy, MD MS
Journal: Blood
Blood (2014) 124 (21): 1740.
https://doi.org/10.1182/blood.V124.21.1740.1740
Published: 2014
Journal Articles

Comparable Outcomes With Bortezomib-Cyclophosphamide-Dexamethasone (VCD) and Bortezomib-Lenalidomide-Dexamethasone (VRD) For Initial Treatment Of Newly Diagnosed Multiple Myeloma (MM)

Shaji K Kumar, MD, Ann E Engebretson, Francis K Buadi, MD, Martha Q Lacy, MD, Angela Dispenzieri, MD, Mei Sheng Duh, MPH, Sc.D, Marie-Hélène Lafeuille, MA, Patrick Lefebvre, MA, B.Sc, Wendy Y Cheng, MPH, MPhil, Katherine Dea, MA, Mark Yap, BSN, RN, Shanmugapriya Saravanan, MS, Iwen Pan, Ph.D, Debra Rembert, RN, MSN, NP, Rahul Dhanda, PhD, Liviu Niculescu, MD, Abbie Ba-Mancini, BS MBA, Esprit Ma, MPH, Maureen Quick, RN, MS, OCN, S. Vincent Rajkumar, MD
Journal: Blood
Blood (2013) 122 (21): 3178.
https://doi.org/10.1182/blood.V122.21.3178.3178
Published: 2013
Journal Articles

Age-Related Iron Chelation Utilization and Healthcare Costs in Patients with Sickle Cell Disease (SCD)

Morey A. Blinder, MD, Francis Vekeman, MA, Alex Trahey, BA, Medha Sasane, PhD, Carole S. Paley, MD, Mei Sheng Duh, MPH, ScD
Journal: Blood
Blood (2011) 118 (21): 338.
https://doi.org/10.1182/blood.V118.21.338.338
Published: 2011
Journal Articles

Age-Related Blood Transfusion Patterns in Patients with Sickle Cell Disease (SCD) and the Association with Sickle Cell Complications

Morey A. Blinder, MD, Francis Vekeman, MA, Alex Trahey, BA, Medha Sasane, PhD, Carole S. Paley, MD, Mei Sheng Duh, MPH, ScD
Journal: Blood
Blood (2011) 118 (21): 12.
https://doi.org/10.1182/blood.V118.21.12.12
Published: 2011
Journal Articles

Molecular Response, Efficacy and Safety Analysis of 168 Adult French Patients with Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) From the ENACT (Expanding Nilotinib Access in Clinical Trials) Study.

Franck Emmanuel Nicolini, MD, PhD, Gabriel Etienne, MD, Dominique Bordessoule, Denis Caillot, MD, Coralie Belanger, Jean-Michel Cayuela, MD, Aude Charbonnier, Valerie Coiteux, MD, Agnès Guerci-Bresler, Viviane Dubruille, Thierry Lamy, MD, PhD, Francoise Huguet, Philippe Rousselot, MD, PhD, Michel Tulliez, Jean-Yves Cahn, Martine Gardembas-Pain, Laurence Legros, MD, Frederic Maloisel, Delphine Rea, MD, PhD, Hyacinthe Johnson-Ansah, MD, Pascal Lenain, Alain Delmer, MD, PhD, Marc Berger, MD, Tomasz Szczudlo, MD, Jim Wang, PhD, Mei Sheng Duh, MPH, ScD, Francois Guilhot, MD
Journal: Blood
Blood (2009) 114 (22): 3293.
https://doi.org/10.1182/blood.V114.22.3293.3293
Published: 2009
Journal Articles

Persistence and Compliance of Deferoxamine Versus Deferasirox in Medicaid Patients with Sickle-Cell Disease.

Lanetta B Jordan, MD, MPH, MSPH, Francis Vekeman, MA, Anirban Sengupta, PhD, Mitra Corral, MPH, MS, Amy Guo, PhD, Mei Sheng Duh, MPH, ScD
Journal: Blood
Blood (2009) 114 (22): 1982.
https://doi.org/10.1182/blood.V114.22.1982.1982
Published: 2009
Journal Articles

Higher Erythroid Response Rates with Epoetin Alfa Versus Other Agents in Treatment-Naïve Low/Int-1 Myelodysplastic Syndrome Patients: A Comparative Meta-Analysis

Suneel Mundle, PhD, Patrick Lefebvre, MA, Francis Vekeman, MA, Mei Sheng Duh, MPH, ScD, François Laliberté, MA, Ruchi Rastogi, PharmD, Victor Moyo, MD
Journal: Blood
Blood (2008) 112 (11): 5074.
https://doi.org/10.1182/blood.V112.11.5074.5074
Published: 2008
Journal Articles

An Economic Evaluation of Bortezomib-Based Induction Therapy in Double Transplant Protocols for Newly Diagnosed Multiple Myeloma Patients

Si-Tien Wang, BA, MS, Mei Sheng Duh, MPH, ScD, Hui Huang, PhD, MBA, Leigh Ann White, PhD, Eva Chang, MPH, Dixie-Lee Esseltine, MD, Jing L. Marantz, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 2386.
https://doi.org/10.1182/blood.V112.11.2386.2386
Published: 2008
Journal Articles

Comparison of Infection-Related Hospitalization Risk and Associated Costs among Patients Receiving Sargramostim (Leukine®), Filgrastim (Neupogen®), and Pegfilgrastim (Neulasta®) for Chemotherapy-Induced Neutropenia

Edmond L Toy, PhD, Francis Vekeman, MA, François Laliberté, MA, Bree Dority, PhD, Daniel Perlman, Victoria Barghout, MSPH, Mei Sheng Duh, MPH, ScD, Mark Lawrence Heaney, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 665.
https://doi.org/10.1182/blood.V112.11.665.665
Published: 2008